Analog Devices
ADI Nasdaq Semiconductors Financials FY2016βFY2025
Analog Devices' revenue rose 16.9% to $11.0 billion in fiscal 2025. Its operating margin was 26.6%, up from 21.6% a year earlier. Free cash flow was $4.3 billion, up 37.0%. It paid out $4.1 billion in dividends and buybacks, 96% of free cash flow. The diluted share count fell 0.4%.
What Analog Devices does
No business description yet.
- Legal name
- ANALOG DEVICES INC
- Fiscal year ends
- November 1, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000006281-25-000153
0000006281
Revenue and margins
Analog Devices had $11.0B of revenue in fiscal 2025, up 16.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 5.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $4.3B in fiscal 2025, 38.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Analog Devices returned $4.1B to shareholders in fiscal 2025, 96% of free cash flow. The diluted share count fell 0.4%.
Value Analog Devices yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.9B and divides by 496.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 46.4x Β· peers 36.9x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Analog Devices can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.0B | $1.5B | $958M | $2.4B | $3.7B |
| Debt incl. finance leases | $6.8B | $6.5B | $6.9B | $8.0B | $8.6B |
| Net debt / EBITDA | 1.7x | 0.9x | 1.0x | 1.4x | 1.0x |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.2x | 0.3x |
| Interest coverage | 9.2x | 16.4x | 14.5x | 6.3x | 9.2x |
| Current ratio | 1.9x | 2.0x | 1.4x | 1.8x | 2.2x |
| Quick ratio | 1.5x | 1.5x | 0.9x | 1.4x | 1.7x |
| Total assets | $52.3B | $50.3B | $48.8B | $48.2B | $48.0B |
| Total liabilities | $14.3B | $13.8B | $13.2B | $13.1B | $14.2B |
| Shareholders' equity | $38.0B | $36.5B | $35.6B | $35.2B | $33.8B |
| Net debt (β = net cash) | $4.8B | $5.1B | $6.0B | $5.6B | $4.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$11.5M
5 insiders
Of sales under plans
70%
$8.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Richard C Puccio JrChief Financial Officer | Sold plan | 1,500 | $389.46 | $0.6M | Form 4 |
| Oct 8, 2026 | Vivek JainChief Operations/Tech Officer | Sold | 3,305 | $406.58 | $1.3M | Form 4 |
| Oct 7, 2026 | Ray StataDirector | Sold plan | 1,416 | $407.38 | $0.6M | Form 4 |
| Oct 7, 2026 | Vivek JainChief Operations/Tech Officer | Sold | 2,000 | $409.79 | $0.8M | Form 4 |
| Oct 6, 2026 | Ray StataDirector | Sold plan | 1,416 | $420.04 | $0.6M | Form 4 |
| Oct 6, 2026 | Richard C Puccio JrChief Financial Officer | Sold plan | 1,500 | $421.08 | $0.6M | Form 4 |
| Oct 2, 2026 | Katsufumi NakamuraChief Customer Officer | Sold | 1,200 | $415.02 | $0.5M | Form 4 |
| Oct 2, 2026 | Vivek JainChief Operations/Tech Officer | Sold | 2,000 | $416.98 | $0.8M | Form 4 |
| Oct 1, 2026 | Vincent RocheChair & CEO, Director | Sold plan | 10,000 | $396.94 | $4.0M | Form 4 |
| Sep 22, 2026 | Richard C Puccio JrChief Financial Officer | Sold plan | 1,500 | $382.19 | $0.6M | Form 4 |
| Sep 9, 2026 | Ray StataDirector | Sold plan | 1,416 | $363.79 | $0.5M | Form 4 |
| Sep 8, 2026 | Richard C Puccio JrEVP and CFO | Sold plan | 1,500 | $363.65 | $0.5M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 5 / 9 | 8 / 9 |
| Accruals ratio | β3.0% | β4.6% | β5.3% |
| Altman Z'' | 4.20 | 4.14 | 4.16 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Analog Devices ADI | $191.2B | 16.9% | 26.6% | 38.8% | 6.2% | 46.4x | 8 | |
| STMicroelectronics STM | $40.6B | β11.1% | 1.5% | β | 0.5% | β | 6 | Compare β |
| NXP Semiconductors NXPI | $59.6B | β2.7% | 24.8% | 19.8% | 12.6% | 22.5x | 4 | Compare β |
| Marvell Technology MRVL | $210.5B | 42.1% | 16.1% | 17.0% | 7.0% | 75.4x | 6 | Compare β |
| Texas Instruments TXN | $262.2B | 13.1% | 34.1% | 14.7% | 21.8% | 36.9x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.4B | $5.1B | $6.2B | $6.0B | $5.6B | $7.3B | $12.0B | $12.3B | $9.4B | $11.0B |
| Gross profit | $2.2B | $3.2B | $4.3B | $4.0B | $3.7B | $4.5B | $7.5B | $7.9B | $5.4B | $6.8B |
| Research and development | $654M | $968M | $1.2B | $1.1B | $1.1B | $1.3B | $1.7B | $1.7B | $1.5B | $1.8B |
| Operating income | $1.0B | $1.2B | $1.9B | $1.7B | $1.5B | $1.7B | $3.3B | $3.8B | $2.0B | $2.9B |
| Interest expense | $88.8M | $251M | $254M | $229M | $193M | $185M | $200M | $265M | $322M | $318M |
| Pretax income | $957M | $935M | $1.7B | $1.5B | $1.3B | $1.3B | $3.1B | $3.6B | $1.8B | $2.7B |
| Income tax | $95.3M | $129M | $148M | $123M | $90.9M | β$61.7M | $350M | $293M | $142M | $445M |
| Net income | $862M | $805M | $1.5B | $1.4B | $1.2B | $1.4B | $2.7B | $3.3B | $1.6B | $2.3B |
| Diluted EPS | $2.76 | $2.29 | $4.00 | $3.65 | $3.28 | $3.46 | $5.25 | $6.55 | $3.28 | $4.56 |
| Diluted shares | 0.31B | 0.35B | 0.37B | 0.37B | 0.37B | 0.40B | 0.52B | 0.51B | 0.50B | 0.50B |
| Cash flow | ||||||||||
| Cash from operations | $1.3B | $1.2B | $2.4B | $2.3B | $2.0B | $2.7B | $4.5B | $4.8B | $3.9B | $4.8B |
| Capital expenditure | $127M | $204M | $255M | $275M | $166M | $344M | $699M | $1.3B | $731M | $534M |
| Free cash flow | $1.2B | $950M | $2.2B | $2.0B | $1.8B | $2.4B | $3.8B | $3.6B | $3.1B | $4.3B |
| Depreciation and amortization | $210M | $584M | $799M | $811M | $811M | $1.1B | $2.3B | $2.3B | $2.1B | $2.0B |
| Stock-based compensation | $63.4M | $104M | $151M | $150M | $150M | $244M | $324M | $300M | $263M | $322M |
| Acquisitions | $83.2M | $9.6B | $52.8M | $11.2M | $0.0M | $2.5B | $0.0M | $0.0M | $0.0M | $45.7M |
| Share buybacks | $370M | $46.5M | $226M | $613M | $245M | $2.6B | $2.6B | $3.0B | $616M | $2.2B |
| Dividends paid | $513M | $602M | $703M | $778M | $886M | $1.1B | $1.5B | $1.7B | $1.8B | $1.9B |
| Dividends and buybacks | $883M | $649M | $929M | $1.4B | $1.1B | $3.7B | $4.1B | $4.6B | $2.4B | $4.1B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $4.1B | $1.0B | $817M | $648M | $1.1B | $2.0B | $1.5B | $958M | $2.4B | $3.7B |
| Total debt | $1.7B | $7.9B | $6.3B | $5.5B | $5.1B | $6.8B | $6.5B | $6.9B | $8.0B | $8.6B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $5.0B | $2.4B | $2.1B | $2.0B | $2.5B | $5.4B | $4.9B | $4.4B | $5.5B | $7.1B |
| Current liabilities | $783M | $1.6B | $1.1B | $1.5B | $1.4B | $2.8B | $2.4B | $3.2B | $3.0B | $3.2B |
| Inventory | $377M | $551M | $587M | $610M | $608M | $1.2B | $1.4B | $1.6B | $1.4B | $1.7B |
| Property and equipment, net | $636M | $1.1B | $1.2B | $1.2B | $1.1B | $2.0B | $2.4B | $3.2B | $3.4B | $3.3B |
| Total assets | $8.0B | $21.1B | $20.4B | $21.4B | $21.5B | $52.3B | $50.3B | $48.8B | $48.2B | $48.0B |
| Total liabilities | $2.8B | $11.0B | $9.2B | $9.7B | $9.5B | $14.3B | $13.8B | $13.2B | $13.1B | $14.2B |
| Shareholders' equity | $5.2B | $10.2B | $11.3B | $11.7B | $12.0B | $38.0B | $36.5B | $35.6B | $35.2B | $33.8B |
| Margins | ||||||||||
| Gross margin | 65.1% | 62.0% | 68.5% | 67.0% | 65.9% | 61.8% | 62.7% | 64.0% | 57.1% | 61.5% |
| Operating margin | 30.1% | 22.8% | 30.6% | 28.6% | 26.7% | 23.1% | 27.3% | 31.1% | 21.6% | 26.6% |
| EBITDA margin | 36.2% | 34.2% | 43.5% | 42.1% | 41.2% | 37.8% | 46.4% | 49.7% | 43.9% | 44.8% |
| Net margin | 25.2% | 15.8% | 24.3% | 22.8% | 21.8% | 19.0% | 22.9% | 26.9% | 17.4% | 20.6% |
| FCF margin | 34.0% | 18.6% | 35.3% | 33.0% | 32.9% | 32.7% | 31.4% | 28.9% | 33.1% | 38.8% |
| Returns | ||||||||||
| Return on capital | 32.2% | 10.1% | 10.3% | 9.4% | 8.5% | 5.8% | 6.9% | 8.5% | 4.5% | 6.2% |
| Return on capital employed | 15.7% | 8.7% | 9.8% | 8.7% | 7.5% | 4.9% | 6.7% | 8.2% | 4.5% | 6.5% |
| Return on equity | 16.8% | 10.5% | 14.1% | 11.9% | 10.3% | 5.6% | 7.4% | 9.2% | 4.6% | 6.6% |
| Return on assets | 11.5% | 5.5% | 7.3% | 6.5% | 5.7% | 3.8% | 5.4% | 6.7% | 3.4% | 4.7% |
| Growth | ||||||||||
| Revenue growth | β0.4% | 49.3% | 21.4% | β3.4% | β6.5% | 30.6% | 64.2% | 2.4% | β23.4% | 16.9% |
| Net income growth | 23.7% | β6.5% | 87.1% | β9.6% | β10.4% | 13.9% | 97.7% | 20.6% | β50.7% | 38.7% |
| EPS growth | 25.5% | β17.0% | 74.7% | β8.8% | β10.1% | 5.5% | 51.7% | 24.8% | β49.9% | 39.0% |
| FCF growth | 54.4% | β18.4% | 130.2% | β9.6% | β6.8% | 29.8% | 57.9% | β5.8% | β12.2% | 37.1% |
| Share count change | β1.4% | 12.2% | 7.0% | β0.6% | β0.2% | 7.9% | 30.4% | β3.3% | β1.4% | β0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β1.9x | 3.9x | 2.0x | 1.9x | 1.8x | 1.7x | 0.9x | 1.0x | 1.4x | 1.0x |
| Debt / equity | 0.3x | 0.8x | 0.6x | 0.5x | 0.4x | 0.2x | 0.2x | 0.2x | 0.2x | 0.3x |
| Interest coverage | 11.6x | 4.6x | 7.5x | 7.5x | 7.8x | 9.2x | 16.4x | 14.5x | 6.3x | 9.2x |
| Current ratio | 6.4x | 1.5x | 2.0x | 1.3x | 1.8x | 1.9x | 2.0x | 1.4x | 1.8x | 2.2x |
| Quick ratio | 5.9x | 1.1x | 1.5x | 0.9x | 1.4x | 1.5x | 1.5x | 0.9x | 1.4x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.7% | 4.0% | 4.1% | 4.6% | 3.0% | 4.7% | 5.8% | 10.3% | 7.8% | 4.8% |
| Stock comp / revenue | 1.9% | 2.0% | 2.4% | 2.5% | 2.7% | 3.3% | 2.7% | 2.4% | 2.8% | 2.9% |
| Payouts / FCF | 75.9% | 68.3% | 42.5% | 70.3% | 61.4% | 155.3% | 109.2% | 130.6% | 77.2% | 95.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 4.0 | 6.0 | 5.0 | 6.0 | 7.0 | 6.0 | 7.0 | 5.0 | 8.0 |
| Altman Z'' | 8.2 | 2.3 | 3.2 | 3.0 | 3.3 | 3.8 | 4.1 | 4.2 | 4.1 | 4.2 |
| Accruals ratio | β5.7% | β2.4% | β4.5% | β4.3% | β3.7% | β3.6% | β3.4% | β3.0% | β4.6% | β5.3% |
Source: SEC EDGAR XBRL filings (CIK 0000006281). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.